2.5(top 20%)
impact factor
28.8K(top 1%)
papers
703.5K(top 1%)
citations
162(top 2%)
h-index
2.5(top 20%)
impact factor
31.5K
all documents
726.7K
doc citations
220(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Physiochemical drug properties associated with in vivo toxicological outcomesBioorganic and Medicinal Chemistry Letters2008749
2The use of spirocyclic scaffolds in drug discoveryBioorganic and Medicinal Chemistry Letters2014739
3Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acidsBioorganic and Medicinal Chemistry Letters1998659
4Carbonic anhydrase inhibitorsBioorganic and Medicinal Chemistry Letters2010579
5Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionBioorganic and Medicinal Chemistry Letters1996565
6The SARS-CoV-2 main protease as drug targetBioorganic and Medicinal Chemistry Letters2020550
7Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancerBioorganic and Medicinal Chemistry Letters2001527
8Antioxidant activity of water-soluble chitosan derivativesBioorganic and Medicinal Chemistry Letters2001503
9Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitorsBioorganic and Medicinal Chemistry Letters2005479
10Rynaxypyr™: A new insecticidal anthranilic diamide that acts as a potent and selective ryanodine receptor activatorBioorganic and Medicinal Chemistry Letters2007440
11The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KBioorganic and Medicinal Chemistry Letters2008419
12Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomicsBioorganic and Medicinal Chemistry Letters2008416
13The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitorBioorganic and Medicinal Chemistry Letters1999413
14Aqua mediated synthesis of substituted 2-amino-4H-chromenes and in vitro study as antibacterial agentsBioorganic and Medicinal Chemistry Letters2005409
155-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicatorsBioorganic and Medicinal Chemistry Letters1991388
16Insecticidal anthranilic diamides: A new class of potent ryanodine receptor activatorsBioorganic and Medicinal Chemistry Letters2005386
17MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization productsBioorganic and Medicinal Chemistry Letters1998384
18GDC-0449—A potent inhibitor of the hedgehog pathwayBioorganic and Medicinal Chemistry Letters2009362
19Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone librariesBioorganic and Medicinal Chemistry Letters2004352
20Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluationBioorganic and Medicinal Chemistry Letters2013348
21A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brainBioorganic and Medicinal Chemistry Letters2002343
22Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13Bioorganic and Medicinal Chemistry Letters2012342
23Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2″-hydroxy naphthalen-1″-yl)-1,5-diphenyl-2-pyrazolinesBioorganic and Medicinal Chemistry Letters2005334
24Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α productionBioorganic and Medicinal Chemistry Letters1999331
25Prediction of drug solubility from Monte Carlo simulationsBioorganic and Medicinal Chemistry Letters2000327
26Potent antimitotic and cell growth inhibitory properties of substituted chalconesBioorganic and Medicinal Chemistry Letters1998324
27Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chainsBioorganic and Medicinal Chemistry Letters2005318
28Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cellsBioorganic and Medicinal Chemistry Letters2004315
29Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic and Medicinal Chemistry Letters2008307
30Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazolesBioorganic and Medicinal Chemistry Letters2004304
31Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activityBioorganic and Medicinal Chemistry Letters2003301
32Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agentsBioorganic and Medicinal Chemistry Letters2004299
33Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum —The η-carbonic anhydrasesBioorganic and Medicinal Chemistry Letters2014297
34Friedländer reaction on 2-amino-3-cyano-4H-pyrans: Synthesis of derivatives of 4H-pyran [2,3-b] quinoline, new tacrine analoguesBioorganic and Medicinal Chemistry Letters1997292
35Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivativesBioorganic and Medicinal Chemistry Letters2005290
36Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomersBioorganic and Medicinal Chemistry Letters1994289
37Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivoBioorganic and Medicinal Chemistry Letters2004289
38Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720Bioorganic and Medicinal Chemistry Letters1995284
39Curcumin is a potent DNA hypomethylation agentBioorganic and Medicinal Chemistry Letters2009284
40Synthesis and anti-pseudomonal activity of new 2-isocephems with a dihydroxypyridone moiety at C-7Bioorganic and Medicinal Chemistry Letters1994280
41Identification of antitumor activity of pyrazole oxime ethersBioorganic and Medicinal Chemistry Letters2005276
42Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agentsBioorganic and Medicinal Chemistry Letters2005273
43Defining optimum lipophilicity and molecular weight ranges for drug candidates—Molecular weight dependent lower logD limits based on permeabilityBioorganic and Medicinal Chemistry Letters2009271
44Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analoguesBioorganic and Medicinal Chemistry Letters2009269
45Synthesis of potent antitumor and antiviral benzofuran derivativesBioorganic and Medicinal Chemistry Letters2009266
46Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitorBioorganic and Medicinal Chemistry Letters2002263
47Drugs, leads, and drug-likeness: an analysis of some recently launched drugsBioorganic and Medicinal Chemistry Letters2002261
48Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus DesmosBioorganic and Medicinal Chemistry Letters2003261
49Anti-HIV coumarins from calophyllum seed oilBioorganic and Medicinal Chemistry Letters1998260
50Synthesis and biological activity of new quinoxaline antibiotics of echinomycin analoguesBioorganic and Medicinal Chemistry Letters2004256